James E. Rothman, PhD

Strategic Advisor to the Board of Directors

Dr. Rothman is an internationally renowned scientist. He was awarded the 2013 Nobel Prize in medicine and has received numerous other honors including the Lasker Basic Research Award. Dr. Rothman is also a biopharmaceutical company founder, life science industry executive, and prestigious academic leader. Dr. Rothman served as chief scientist and executive committee member at GE Healthcare, a $15B unit of General Electric Corporation. Prior to the acquisition of Amersham Biosciences PLC by GE Healthcare, Dr. Rothman served as chief scientist at Amersham. His distinguished academic career includes endowed chairs at Memorial Sloan-Kettering Cancer Center where he served as vice-chair of the Sloan-Kettering Institute; Columbia University’s College of Physicians and Surgeons; and Yale University, where he is currently professor and chair of cell biology and executive director for high throughput cell biology. He is a member of the National Academy of Sciences, a member of the Institute of Medicine of the National Academy of Sciences, and fellow of the American Academy of Arts and Sciences.

Achievements

  • 2013 Nobel Prize Laureate in Medicine and Physiology
  • National Academy of Sciences and Institute of Medicine. Endowed chairs at Memorial Sloan Kettering, Columbia University’s College of Physicians and Surgeons, and Yale University
 
STAY IN THE KNOW WITH
EMAIL NEWS ALERTS
 
Don't miss out. Get our news delivered to your inbox.
 

 
close-link
 
Get Email News Alerts
 
close-link